| 今开：0.0 | 昨收：12.01 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.8627613E7 |
$Aeglea生物制药(AGLE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-066146 Size: 5 KB 网页链接
$Aeglea生物制药(AGLE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-066131 Size: 9 KB 网页链接
$Aeglea生物制药(AGLE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-066136 Size: 10 KB 网页链接
$Aeglea生物制药(AGLE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-066141 Size: 12 KB 网页链接
$Aeglea生物制药(AGLE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-066143 Size: 5 KB 网页链接
$Aeglea生物制药(AGLE)$ 8-K Current report, items 5.03, 5.07, 7.01, and 9.01 Accession Number: 0001193125-23-282424 Act: 34 Size: 179 KB 网页链接
$Aeglea生物制药(AGLE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003387 Act: 33 Size: 1 KB 网页链接
$Aeglea生物制药(AGLE)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-23-277992 Act: 33 Size: 6 MB 网页链接
$Aeglea生物制药(AGLE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-277985 Act: 34 Size: 798 KB 网页链接
$Aeglea生物制药(AGLE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001683168-23-008109 Act: 34 Size: 46 KB 网页链接